April 11, 2021
Business News

AstraZeneca pauses COVID-19 vaccine trial over possible adverse reaction in participant – CBS News

AstraZeneca on Tuesday temporarily halted its phase three trials of a possible coronavirus vaccine after one participant suffered what may have been a serious adverse reaction. The vaccine “candidate” was developed by the pharmaceutical giant along with Oxford University and is currently being tested in large-scale human trials in the U.K., the U.S., Brazil and South Africa.
All of those trials have been put on hold to give scientists time to scrutinize data, and the individual who showed the …

Click here to view the original article.

Related Posts

You might also like ...

Article feature image
Bank earnings, retail sales: What to know this week – Yahoo Finance
Article feature image
South African variant may evade protection from Pfizer vaccine, Israeli study says – Reuters
“Godzilla vs. Kong” Continues to Dominate the Global Box Office, Amassing Over $350 Million in Its First Weeks